LYEL Stock Fluctuations: The Real Story
H.C. Wainwright has recently reduced Lyell Immunopharma Inc (LYEL) stock to Neutral rating, as announced on June 27, 2024, according to Finviz. Earlier, on August 28, 2023, JP Morgan had reduced the stock from a Overweight to Neutral, setting a price target of $5 for LYEL stock. Morgan Stanley also reduced their rating with a […]
Lyell Immunopharma Inc (LYEL) Stock: A Deeper Look at Its True Potential
H.C. Wainwright has recently reduced Lyell Immunopharma Inc (LYEL) stock to Neutral rating, as announced on June 27, 2024, according to Finviz. Earlier, on August 28, 2023, JP Morgan had reduced the stock from a Overweight to Neutral, setting a price target of $5 for LYEL stock. Morgan Stanley also reduced their rating with a […]
Why Did Lyell Immunopharma Inc (LYEL) Plummet? Key Factors Explained
H.C. Wainwright has recently reduced Lyell Immunopharma Inc (LYEL) stock to Neutral rating, as announced on June 27, 2024, according to Finviz. Earlier, on August 28, 2023, JP Morgan had reduced the stock from a Overweight to Neutral, setting a price target of $5. for LYEL stock. Morgan Stanley also reduced their rating with a […]
Lyell Immunopharma Inc (LYEL) Stock: Beyond the Surface of Its Performance?
H.C. Wainwright has recently reduced Lyell Immunopharma Inc (LYEL) stock to Neutral rating, as announced on June 27, 2024, according to Finviz. Earlier, on August 28, 2023, JP Morgan had reduced the stock from a Overweight to Neutral, setting a price target of $5 for LYEL stock. Morgan Stanley also reduced their rating with a […]
What’s Behind the 12.10% Gain in Lyell Immunopharma Inc (LYEL) Stock? Find Out Now!
H.C. Wainwright has recently reduced Lyell Immunopharma Inc (LYEL) stock to Neutral rating, as announced on June 27, 2024, according to Finviz. Earlier, on August 28, 2023, JP Morgan had reduced the stock from a Overweight to Neutral, setting a price target of $5. for LYEL stock. Morgan Stanley also reduced their rating with a […]
What’s Fueling Lyell Immunopharma Inc (LYEL) Stock’s -43.31% Loss Below Its 200-Day SMA?
H.C. Wainwright has recently reduced Lyell Immunopharma Inc (LYEL) stock to Neutral rating, as announced on June 27, 2024, according to Finviz. Earlier, on August 28, 2023, JP Morgan had reduced the stock from a Overweight to Neutral, setting a price target of $5 for LYEL stock. Morgan Stanley also reduced their rating with a […]
Lyell Immunopharma Inc (LYEL) Stock: A Deeper Look at Its True Potential
H.C. Wainwright has recently reduced Lyell Immunopharma Inc (LYEL) stock to Neutral rating, as announced on June 27, 2024, according to Finviz. Earlier, on August 28, 2023, JP Morgan had reduced the stock from a Overweight to Neutral, setting a price target of $5. for LYEL stock. Morgan Stanley also reduced their rating with a […]
Lyell Immunopharma Inc (LYEL) Stock: Surpassing Expectations in the Market?
H.C. Wainwright has recently reduced Lyell Immunopharma Inc (LYEL) stock to Neutral, as announced on June 27, 2024 according to Finviz. Earlier, on August 28, 2023, JP Morgan had reduced the stock from a Overweight to Neutral, setting a price target of $5 for LYEL stock. Morgan Stanley also downgraded their rating with a price […]
Why Did Lyell Immunopharma Inc (LYEL) Stock Plunge -20.26% Last Week?
H.C. Wainwright has recently reduced Lyell Immunopharma Inc (LYEL) stock to Neutral, as announced on June 27, 2024 according to Finviz. Earlier, on August 28, 2023, JP Morgan had reduced the stock from a Overweight to Neutral, setting a price target of $5 for LYEL stock. Morgan Stanley also downgraded their rating with a price […]
What is happening with Lyell Immunopharma Inc (LYEL) Stock?
H.C. Wainwright lowered the price target for the Lyell Immunopharma Inc (NASDAQ:LYEL) stock from “a Buy” to “a Neutral”. The rating was released on June 27, 2024, according to finviz. We previously noted in another research note published on August 28, 2023 by JP Morgan that downgraded the stock from an Overweight to a Neutral […]
